FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist

FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist

FGF9 is a potent mitogen and survival factor, but FGF9 protein levels are generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in cancer. However, the mechanism of FGF9 action has not been fully established. Previous studies showed that FGF1 and FGF2 direct...

Full description

Bibliographic Details
Main Authors: Chih-Chieh Chang, Yoko K. Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cells
Subjects:
FGF9
integrin
dominant-negative effect
signaling
FGFR3
mutagenesis
Online Access:https://www.mdpi.com/2073-4409/13/4/307

Similar Items

Similar Items